BTIG Research Reiterates “Neutral” Rating for Globus Medical (NYSE:GMED)
Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “neutral” rating restated by analysts at BTIG Research in a research report issued on Tuesday, Marketbeat Ratings reports. Several other analysts have also weighed in on the company. Stifel Nicolaus upped their target price on Globus Medical from $92.00 to $94.00 and gave the company […]
Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “neutral” rating restated by analysts at BTIG Research in a research report issued on Tuesday, Marketbeat Ratings reports. Several other analysts have also weighed in on the company. Stifel Nicolaus upped their target price on Globus Medical from $92.00 to $94.00 and gave the company […]
